Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES   WINTER 2008 , Volume 15 , Number 4; Page(s) 16 To 20.
 
Paper: 

REFRACTORY STATUS EPILEPTICUS IN CHILDREN; RISK FACTORS MANAGEMENT AND EARLY OUTCOME

 
 
Author(s):  BARZEGAR MOHAMMAD, JAFARI ROUHI A.H.*
 
* PEDIATRIC EMERGENCY MEDICINE, SCHOOL OF MEDICINE, TABRIZ UNIVERSITY OF MEDICAL SCIENCES AND HEATH SERVICES, TABRIZ, IRAN
 
Abstract: 
Introduction: Refractory status epilepticus is a life-threatening disease in children wherein seizure movements don't response to first line anti convulsion drugs. This study reviewed risk factors, management and early outcome of children with refractory status epilepticus.methods: Patients with refractory status epilepticus admitted in Tabriz children's hospital between 2003 and 2006 were reviewed prospectively for risk factors, management and outcome at time of discharge from hospital.Results: Of the total of 121 patients with status epilepticus, 47 patients (38.8%) were afflicted with refractory status epilepticus. The most common form of refractory status epilepticus was acute symptomatic (38.3%).Seizure caused by acute symptomatic [RR= 2.36, (CI 95%=1.25 - 4.44), P=0.006] was a risk factor for refractory status epilepticus development. 87.2% of patients with refractory status epilepticus were treated by midazolam infusion. There was no significant relation between non-response to midazolam, etiology (P=0.798) and type of seizure (P=0.273). Early outcome of children with refractory status epilepticus was significantly worse than those with status epilepticus (P=0.0001).Conclusion: About 38% of patients with status epilepticus develop refractory status epilepticus with an increased mortality and morbidity. Seizure caused by acute symptomatic is an important risk factor for developing refractory status epilepticus. In most cases, midazolam infusion rhesus in end of seizure.
 
Keyword(s): REFRACTORY STATUS EPILEPTICUS, INTRAVENOUS MIDAZOLAM, MORTALITY, MORBIDITY
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

BARZEGAR, M., & JAFARI ROUHI, A. (2008). REFRACTORY STATUS EPILEPTICUS IN CHILDREN; RISK FACTORS MANAGEMENT AND EARLY OUTCOME. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, 15(4), 16-20. https://www.sid.ir/en/journal/ViewPaper.aspx?id=118166



Vancouver: Copy

BARZEGAR MOHAMMAD, JAFARI ROUHI A.H.. REFRACTORY STATUS EPILEPTICUS IN CHILDREN; RISK FACTORS MANAGEMENT AND EARLY OUTCOME. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES. 2008 [cited 2021December02];15(4):16-20. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=118166



IEEE: Copy

BARZEGAR, M., JAFARI ROUHI, A., 2008. REFRACTORY STATUS EPILEPTICUS IN CHILDREN; RISK FACTORS MANAGEMENT AND EARLY OUTCOME. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, [online] 15(4), pp.16-20. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=118166.



 
 
Persian Abstract Yearly Visit 53
 
 
Latest on Blog
Enter SID Blog